Protective Effects of Glycycoumarin on Liver Diseases

Enxiang Zhang,Shutao Yin,Shuang Zhao,Chong Zhao,Mingzhu Yan,Lihong Fan,Hongbo Hu
DOI: https://doi.org/10.1002/ptr.6598
2019-01-01
Abstract:Licorice, an edible and medicinal plant, has long been used to treat various diseases, including liver diseases. Glycycoumarin (GCM) is a representative coumarin compound in licorice with favorable bioavailability feature. Recent studies by us demonstrated that GCM is highly effective against alcoholic liver disease, nonalcoholic fatty liver disease, acetaminophen‐induced hepatotoxicity, and liver cancer through mechanisms involved in activation of Nrf2 antioxidant system, stimulation of AMPK‐mediated energy homeostasis, induction of autophagy degradation process, and inhibiting oncogenic kinase T‐lymphokine–activated killer cell‐originated protein kinase activity. In this review, we summarize the findings on the hepatoprotective effect of GCM, discuss the signaling pathways underlying GCM‐induced protective effect on liver diseases, and propose the issues that need to be addressed to promote further development of GCM as a clinically useful hepatoprotective agent.
What problem does this paper attempt to address?